Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery

Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new cases and 1.5 million deaths in 2020. TB is caused by infection with the major human pathogen <i>Mycobacterium tuberculosis</i>, which is difficult to rapidly diagnose and treat. There is an urgent ne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Antonia Molloy, James Harrison, John S. McGrath, Zachary Owen, Clive Smith, Xin Liu, Xin Li, Jonathan A. G. Cox
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/18e9a61d9f4b42b7976d2b9eb9728489
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!